UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.556

Sortiert nach

Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2021-04, Vol.32 (4), p.452-465

2021

Link zum Volltext

Verfügbarkeit prüfen

Digital health for optimal supportive care in oncology: benefits, limits, and future perspectives

Supportive care in cancer, 2020-10, Vol.28 (10), p.4589-4612

2020

Link zum Volltext

Verfügbarkeit prüfen

Addressing the quality of life needs of older patients with cancer: a SIOG consensus paper and practical guide

Annals of oncology, 2018-08, Vol.29 (8), p.1718-1726

2018

Link zum Volltext

Verfügbarkeit prüfen

Pain management in head and neck cancer patients undergoing chemo-radiotherapy: Clinical practical recommendations

Critical reviews in oncology/hematology, 2016-03, Vol.99, p.100-106

2016

Link zum Volltext

Verfügbarkeit prüfen

ESMO–EURACAN Clinical Practice Guideline update for nasopharyngeal carcinoma: adjuvant therapy and first-line treatment of recurrent/metastatic disease

Annals of oncology, 2023-03, Vol.34 (3), p.247-250

2023

Link zum Volltext

Verfügbarkeit prüfen

Elapsed time for an unresolved adverse event: systemic anticancer therapy-induced neurotoxicity calls for action

Annals of oncology, 2020-10, Vol.31 (10), p.1289-1290

2020

Link zum Volltext

Verfügbarkeit prüfen

Preoperative chemotherapy in advanced resectable OCSCC: long-term results of a randomized phase III trial

Annals of oncology, 2014-02, Vol.25 (2), p.462-466

2014

Link zum Volltext

Verfügbarkeit prüfen

Preventive action with a population of excavator drivers exposed to whole-body vibration

Work (Reading, Mass.), 2021-01, Vol.68 (2), p.473-481

2021

Link zum Volltext

Verfügbarkeit prüfen

Diarrhoea in adult cancer patients: ESMO Clinical Practice Guidelines

Annals of oncology, 2018-10, Vol.29 (Supplement_4), p.iv126-iv142

2018

Link zum Volltext

Verfügbarkeit prüfen

The pathogenesis of mucositis: updated perspectives and emerging targets

Supportive care in cancer, 2019-10, Vol.27 (10), p.4023-4033

2019

Link zum Volltext

Verfügbarkeit prüfen

De novo metastatic head and neck squamous cell carcinoma: Why does locoregional control “always” matter?

Oral oncology, 2024-05, Vol.152, p.106768-106768, Article 106768

2024

Link zum Volltext

Verfügbarkeit prüfen

Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study

Oral oncology, 2009-07, Vol.45 (7), p.574-578

2009

Link zum Volltext

Verfügbarkeit prüfen

A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatin

Annals of oncology, 2017-10, Vol.28 (10), p.2547-2551

2017

Link zum Volltext

Verfügbarkeit prüfen

Management of Tyrosine Kinase Inhibitors (TKI) Side Effects in Differentiated and Medullary Thyroid Cancer Patients

Best Practice & Research Clinical Endocrinology & Metabolism, 2017-06, Vol.31 (3), p.349-361

2017

Link zum Volltext

Verfügbarkeit prüfen

Prediction of mucositis risk secondary to cancer therapy: a systematic review of current evidence and call to action

Supportive care in cancer, 2020-11, Vol.28 (11), p.5059-5073

2020

Link zum Volltext

Verfügbarkeit prüfen

Comprehensive gene expression meta-analysis of head and neck squamous cell carcinoma microarray data defines a robust survival predictor

Annals of oncology, 2014-08, Vol.25 (8), p.1628-1635

2014

Link zum Volltext

Verfügbarkeit prüfen

A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck

Annals of oncology, 2017-11, Vol.28 (11), p.2820-2826

2017

Link zum Volltext

Verfügbarkeit prüfen

A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact

European journal of cancer (1990), 2016-12, Vol.69, p.158-165

2016

Link zum Volltext

Verfügbarkeit prüfen

Pretreatment DWI with Histogram Analysis of the ADC in Predicting the Outcome of Advanced Oropharyngeal Cancer with Known Human Papillomavirus Status Treated with Chemoradiation

American journal of neuroradiology : AJNR, 2020-08, Vol.41 (8), p.1473-1479

2020

Link zum Volltext

Verfügbarkeit prüfen

Activity and safety of afatinib in a window preoperative EORTC study in patients with squamous cell carcinoma of the head and neck (SCCHN)

Annals of oncology, 2018-04, Vol.29 (4), p.985-991

2018

Link zum Volltext

Verfügbarkeit prüfen

Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation study

Annals of oncology, 2012-07, Vol.23 (7), p.1832-1837

2012

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer

European journal of cancer (1990), 2018-07, Vol.97, p.7-15

2018

Link zum Volltext

Verfügbarkeit prüfen

Do not throw the baby out with the bathwater: SELECT a personalized, de-escalated lenvatinib schedule allows response in locally advanced DTC while controlling major drug-related bleeding

Annals of oncology, 2017-09, Vol.28 (9), p.2321-2322

2017

Link zum Volltext

Verfügbarkeit prüfen

Rationale and budget impact of bimonthly use of Cetuximab in patients with recurrent and/or metastatic head and neck cancer

Head & neck, 2019-04, Vol.41 (4), p.908-914

2019

Link zum Volltext

Verfügbarkeit prüfen

Difficulties in conducting pure academic research, obstacles in data collection and quality of informations: The example of the INTERCEPTOR study

Oral oncology, 2019-10, Vol.97, p.99-104

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.556

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.335)
Mit Volltextzugriff
(1.369)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

Digital health for optimal supportive care in oncology: benefits, limits, and future perspectives

Addressing the quality of life needs of older patients with cancer: a SIOG consensus paper and practical guide

Pain management in head and neck cancer patients undergoing chemo-radiotherapy: Clinical practical recommendations

ESMO–EURACAN Clinical Practice Guideline update for nasopharyngeal carcinoma: adjuvant therapy and first-line treatment of recurrent/metastatic disease

Elapsed time for an unresolved adverse event: systemic anticancer therapy-induced neurotoxicity calls for action

Preoperative chemotherapy in advanced resectable OCSCC: long-term results of a randomized phase III trial

Preventive action with a population of excavator drivers exposed to whole-body vibration

Diarrhoea in adult cancer patients: ESMO Clinical Practice Guidelines

The pathogenesis of mucositis: updated perspectives and emerging targets

De novo metastatic head and neck squamous cell carcinoma: Why does locoregional control “always” matter?

Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study

A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatin

Management of Tyrosine Kinase Inhibitors (TKI) Side Effects in Differentiated and Medullary Thyroid Cancer Patients

Prediction of mucositis risk secondary to cancer therapy: a systematic review of current evidence and call to action

Comprehensive gene expression meta-analysis of head and neck squamous cell carcinoma microarray data defines a robust survival predictor

A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck

A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact

Pretreatment DWI with Histogram Analysis of the ADC in Predicting the Outcome of Advanced Oropharyngeal Cancer with Known Human Papillomavirus Status Treated with Chemoradiation

Activity and safety of afatinib in a window preoperative EORTC study in patients with squamous cell carcinoma of the head and neck (SCCHN)

Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation study

Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer

Do not throw the baby out with the bathwater: SELECT a personalized, de-escalated lenvatinib schedule allows response in locally advanced DTC while controlling major drug-related bleeding

Rationale and budget impact of bimonthly use of Cetuximab in patients with recurrent and/or metastatic head and neck cancer

Difficulties in conducting pure academic research, obstacles in data collection and quality of informations: The example of the INTERCEPTOR study

Suchergebnisse filtern